Legal News

EMA publishes Q&A on interchangeability of biosimilar medicines in EU

Published on: 27 January 2023
Published by LNB News

LNB News 27/01/2023

Document Information

Issue Date: 27 January 2023

Published Date: 27 January 2023

Jurisdiction(s): European Union

Article summary

The European Medicines Agency (EMA) has published a Q&A on the interchangeability of biosimilar medicines, that contain active substances from a biological source, across the EU. EMA provides information for patients and healthcare professionals, as well an overview of biosimilar development and approval in the EU and regulatory guidance.

Popular documents